Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06588608 · ClinicalTrials.gov registry record · NA

Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI)

A NA study of Spinal Cord Injuries, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT06588608: Recruiting NA study of Spinal Cord Injuries, sponsored by University of Miami.

NCT06588608 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by University of Miami. The registered enrollment target is 16 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06588608, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to test if Auricular Vagal Nerve Stimulation (aVNS) is safe in persons with spinal cord injury (SCI).

Primary Outcome

Safety will be reported as the number of treatment-related AEs assessed by study PI or physician

Conditions Studied

Interventions

  • DEVICE auricular nerve stimulation (aVNS)
  • DEVICE sham aVNS

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2025-02-04
Est. Completion 2026-12-31
Phase NA
University of Miami

721 total trials

What NCT06588608 shows while recruiting

NCT06588608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which auricular nerve stimulation (aVNS) is the first listed.

NCT06588608 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06588608 about?

NCT06588608 is a clinical study titled "Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI)". The purpose of this research is to test if Auricular Vagal Nerve Stimulation (aVNS) is safe in persons with spinal cord injury (SCI).

What is the current status of trial NCT06588608?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-02-04. Estimated completion is 2026-12-31.

What conditions does trial NCT06588608 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT06588608?

The interventions under investigation include: auricular nerve stimulation (aVNS) (DEVICE), sham aVNS (DEVICE).

Who is sponsoring clinical trial NCT06588608?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06588608 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06588608's enrollment target sits among peer trials

16 145th of 202 higher than 53 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06588608, the US trial registry maintained by the National Library of Medicine. NCT06588608 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.